Login / Signup
Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.
Aristeidis Chaidos
Alexia Katsarou
Chira Mustafa
Dragana Milojkovic
Anastasios Karadimitris
Published in:
British journal of haematology (2020)
Keyphrases
</>
multiple myeloma
coronavirus disease
sars cov
early onset
combination therapy
respiratory syndrome coronavirus
drug induced